These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 20140513)

  • 1. Microbial engineering of dehydro-amino acids and lanthionines in non-lantibiotic peptides.
    Moll GN; Kuipers A; Rink R
    Antonie Van Leeuwenhoek; 2010 May; 97(4):319-33. PubMed ID: 20140513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lantibiotic structures as guidelines for the design of peptides that can be modified by lantibiotic enzymes.
    Rink R; Kuipers A; de Boef E; Leenhouts KJ; Driessen AJ; Moll GN; Kuipers OP
    Biochemistry; 2005 Jun; 44(24):8873-82. PubMed ID: 15952794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
    Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
    J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering dehydro amino acids and thioethers into peptides using lacticin 481 synthetase.
    Chatterjee C; Patton GC; Cooper L; Paul M; van der Donk WA
    Chem Biol; 2006 Oct; 13(10):1109-17. PubMed ID: 17052615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biosynthesis of lanthionine-constrained agonists of G protein-coupled receptors.
    Moll GN; Kuipers A; Rink R; Bosma T; de Vries L; Namsolleck P
    Biochem Soc Trans; 2020 Oct; 48(5):2195-2203. PubMed ID: 33125486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity.
    Martin NI; Sprules T; Carpenter MR; Cotter PD; Hill C; Ross RP; Vederas JC
    Biochemistry; 2004 Mar; 43(11):3049-56. PubMed ID: 15023056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetics of lantibiotic biosynthesis.
    Jack R; Bierbaum G; Heidrich C; Sahl HG
    Bioessays; 1995 Sep; 17(9):793-802. PubMed ID: 8763832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NisC, the cyclase of the lantibiotic nisin, can catalyze cyclization of designed nonlantibiotic peptides.
    Rink R; Kluskens LD; Kuipers A; Driessen AJ; Kuipers OP; Moll GN
    Biochemistry; 2007 Nov; 46(45):13179-89. PubMed ID: 17929939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-translational modification of therapeutic peptides by NisB, the dehydratase of the lantibiotic nisin.
    Kluskens LD; Kuipers A; Rink R; de Boef E; Fekken S; Driessen AJ; Kuipers OP; Moll GN
    Biochemistry; 2005 Sep; 44(38):12827-34. PubMed ID: 16171398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lantibiotics: insight and foresight for new paradigm.
    Nagao J; Asaduzzaman SM; Aso Y; Okuda K; Nakayama J; Sonomoto K
    J Biosci Bioeng; 2006 Sep; 102(3):139-49. PubMed ID: 17046525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering unusual amino acids into peptides using lantibiotic synthetase.
    Nagao J; Shioya K; Harada Y; Okuda K; Zendo T; Nakayama J; Sonomoto K
    Methods Mol Biol; 2011; 705():225-36. PubMed ID: 21125389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial lantibiotics: strategies to improve therapeutic potential.
    Cotter PD; Hill C; Ross RP
    Curr Protein Pept Sci; 2005 Feb; 6(1):61-75. PubMed ID: 15638769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unique peptide modifications involved in the biosynthesis of lantibiotics.
    Jack RW; Sahl HG
    Trends Biotechnol; 1995 Jul; 13(7):269-78. PubMed ID: 7646850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Throughput Screening for Substrate Specificity-Adapted Mutants of the Nisin Dehydratase NisB.
    Zhao X; Cebrián R; Fu Y; Rink R; Bosma T; Moll GN; Kuipers OP
    ACS Synth Biol; 2020 Jun; 9(6):1468-1478. PubMed ID: 32374981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete alanine scanning of the two-component lantibiotic lacticin 3147: generating a blueprint for rational drug design.
    Cotter PD; Deegan LH; Lawton EM; Draper LA; O'Connor PM; Hill C; Ross RP
    Mol Microbiol; 2006 Nov; 62(3):735-47. PubMed ID: 17076667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concise preparation of tetra-orthogonally protected (2S,6R)-lanthionines.
    Martin NI
    J Org Chem; 2009 Jan; 74(2):946-9. PubMed ID: 19046137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NisT, the transporter of the lantibiotic nisin, can transport fully modified, dehydrated, and unmodified prenisin and fusions of the leader peptide with non-lantibiotic peptides.
    Kuipers A; de Boef E; Rink R; Fekken S; Kluskens LD; Driessen AJ; Leenhouts K; Kuipers OP; Moll GN
    J Biol Chem; 2004 May; 279(21):22176-82. PubMed ID: 15044440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of peptides containing overlapping lanthionine bridges on the solid phase: an analogue of rings D and E of the lantibiotic nisin.
    Mothia B; Appleyard AN; Wadman S; Tabor AB
    Org Lett; 2011 Aug; 13(16):4216-9. PubMed ID: 21766788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-function relationships of the lanthionine cyclase SpaC involved in biosynthesis of the Bacillus subtilis peptide antibiotic subtilin.
    Helfrich M; Entian KD; Stein T
    Biochemistry; 2007 Mar; 46(11):3224-33. PubMed ID: 17305367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A concise stereoselective synthesis of orthogonally protected lanthionine and beta-methyllanthionine.
    Cobb SL; Vederas JC
    Org Biomol Chem; 2007 Apr; 5(7):1031-8. PubMed ID: 17377656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.